Loading clinical trials...
Loading clinical trials...
Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Chronic Migraine and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (PREDICT)
This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Foothills Medical Centre
Calgary, Alberta, Canada
Hys Medical Centre
Edmonton, Alberta, Canada
Bayside Medical Centre
Brentwood Bay, British Columbia, Canada
Jeff Oyler
Kamloops, British Columbia, Canada
Dhawan Medical Corporation Medical Clinic
Vancouver, British Columbia, Canada
May Ong-Lam
Vancouver, British Columbia, Canada
Island Neurology
Victoria, British Columbia, Canada
Hamilton Headache Clinic
Hamilton, Ontario, Canada
The Shapero Markham Headache and Pain Treatment Centre
Markham, Ontario, Canada
Pain Care Clinics
Mississauga, Ontario, Canada
Start Date
July 2, 2015
Primary Completion Date
January 29, 2019
Completion Date
January 29, 2019
Last Updated
April 5, 2019
215
ACTUAL participants
No Intervention
OTHER
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05690737